Issue Information
6 June 2021
REPLY:
Salvatore Piano, Paolo Angeli – 6 June 2021
Prevalence of HBV Infection, Vaccine‐Induced Immunity, and Susceptibility Among At‐Risk Populations: US Households, 2013‐2018
Henry Roberts, Kathleen N. Ly, Shaoman Yin, Elizabeth Hughes, Eyasu Teshale, Ruth Jiles – 6 June 2021
Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol‐Associated Hepatitis
Zhihong Yang, Ting Zhang, Praveen Kusumanchi, Qing Tang, Zhaoli Sun, Svetlana Radaeva, Brandon Peiffer, Vijay H. Shah, Patrick Kamath, Greg J. Gores, Arun Sanyal, Naga Chalasani, Yanchao Jiang, Nazmul Huda, Jing Ma, Suthat Liangpunsakul – 6 June 2021
Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
Tiffany Cho‐Lam Wong, Victor Ho‐Fun Lee, Ada Lai‐Yau Law, Herbert H. Pang, Ka‐On Lam, Vince Lau, Tracy Yushi Cui, Adrianna Sze‐Yin Fong, Sarah Wai‐Man Lee, Edwin Chun‐Yin Wong, Jeff Wing‐Chiu Dai, Albert Chi‐Yan Chan, Tan‐To Cheung, James Yan‐Yue Fung, Rebecca Mei‐Wan Yeung, Mai‐Yee Luk, To‐Wai Leung, Chung‐Mau Lo – 5 June 2021
Letter to the Editor: Response to Terlipressin Plus Albumin in Hepatorenal Syndrome—Need a Closer Look!
Ankur Jindal, Rakesh K. Jagdish – 5 June 2021
Familial Hypobetalipoproteinemia: An Underrecognized Cause of Lean NASH
Seth Buryska, Joseph C. Ahn, Alina M. Allen, Vinaya Simha, Douglas A. Simonetto – 4 June 2021
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic
Meaghan M. Phipps, Elizabeth C. Verna – 4 June 2021 – Over the last year, the novel coronavirus disease 2019 (COVID‐19) has continued to spread across the globe, causing significant morbidity and mortality among transplantation candidates and recipients. Patients with end‐stage liver disease awaiting liver transplantation and patients with a history of liver transplantation represent vulnerable populations, especially given the high rates of associated medical comorbidities in these groups and their immunosuppressed status.
Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice
Wu Yang, Hao He, Tongtong Wang, Nan Su, Feng Zhang, Kai Jiang, Jing Zhu, Chonghe Zhang, Kongyan Niu, Luyue Wang, Xiaodong Yuan, Nan Liu, Lingjie Li, Wu Wei, Junhao Hu – 4 June 2021
The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single‐Center Analysis
Kristel K. Leung, Audrey Kim, Bettina E. Hansen, Les Lilly, Nazia Selzner, Keyur Patel, Mamatha Bhat, Gideon M. Hirschfield, Zita Galvin – 4 June 2021 – Organ allocation in liver transplantation (LT) remains imperfect. Periodic center reviews ensure programs transparently evaluate the impact of practice on access to transplantation, reflecting, in particular, patient (primary disease, social determinants) and program (deceased versus live donation) factors. Adult Ontario residents waitlisted for first LT at Toronto General Hospital from November 2012 to May 2019 were reviewed.